Parâmetros que demonstram ter influência na resposta à terapia neoadjuvante em pacientes com cancro da mama: Estado da arte e perspetivas futuras

Dados básicos

Código:
Estudo Clínico Académico
Protocolo:
Estudo Clínico Académico
EUDRACT:
NCT:
Centro:
Dotação:
Ano de início:
2021
Ano de conclusão:
Estudos observacionais Nacional Não Financiado Outros

Objectivos do projeto

Estudos Observacionais (STROBE statement); Natureza do Promotor: Academia – Tipo não comercial – Iniciativa do Investigador; Tipo de Centro: Unicêntrico – Cuidados Secundários

Documentos

  • Não há documentos

Participantes

Unidades de investigação

Stakeholders - Promotores

FMUP

Outputs do ensaio clínico


Anatomy and Physiology of the Breast

Tse G., Tan P.-H., Schmitt F.

Book Chapter. 10.1007/978-3-031-26900-4_1. 2023


Ancillary Studies in Urinary Cytology

Bubendorf L.; (...); Vielh P.

Book Chapter. 10.1007/978-3-030-88686-8_9. 2022


Aspiration Techniques

Pinto D.G.; (...); Schmitt F.

Book Chapter. 10.1007/978-3-031-26900-4_3. 2023


Assessment of Axillary Nodes

Wong J.S.L.; (...); Schmitt F.

Book Chapter. 10.1007/978-3-031-26900-4_15. 2023


Basic Histopathology of Breast Lesions

Tse G., Tan P.-H., Schmitt F.

Book Chapter. 10.1007/978-3-031-26900-4_2. 2023


Breast Fine Needle Aspiration Cytology: Introduction to the Yokohama Classification

Brachtel E.F.; (...); Tan P.-H.

Book Chapter. 10.1007/978-3-031-26900-4_5. 2023


Carcinoma and Variants

Tse G.; (...); Gudi M.

Book Chapter. 10.1007/978-3-031-26900-4_13. 2023


Comparison of Aspiration and Core Needle Biopsy

Tse G., Tan P.-H., Schmitt F.

Book Chapter. 10.1007/978-3-031-26900-4_18. 2023


Cytology of Epithelial Proliferative Lesions and High-Grade Ductal Carcinoma In Situ

Li J.; (...); Sneige N.

Book Chapter. 10.1007/978-3-031-26900-4_10. 2023


False Positive in Thyroid FNA: Causes and How to Avoid Them

Schmitt F., da Silva R.S.

Book Chapter. 10.1007/978-981-99-6782-7_30. 2024


Fibroadenoma

Gudi M.; (...); Schmitt F.

Book Chapter. 10.1007/978-3-031-26900-4_8. 2023


Fibrocystic Changes and Cysts

Callé C.; (...); Tan P.-H.

Book Chapter. 10.1007/978-3-031-26900-4_7. 2023


Future Directions

Tse G., Tan P.-H., Schmitt F.

Book Chapter. 10.1007/978-3-031-26900-4_19. 2023


Inflammatory Lesions of the Breast

Ni Y.; (...); Schmitt F.

Book Chapter. 10.1007/978-3-031-26900-4_6. 2023


Liquid-Based Cytology and Cell Block in Breast Lesions

Pinto D.G.; (...); Schmitt F.

Book Chapter. 10.1007/978-3-031-26900-4_4. 2023


Molecular Pathology of Endometrial Carcinoma on LBC Samples and Cell Blocks

Martins D.; (...); Fulciniti F.

Book Chapter. 10.1007/978-981-16-5011-6_16. 2022


Molecular Pathology of Endometrial Carcinoma: A General Appraisal

Di Lorito A.; (...); Fulciniti F.

Book Chapter. 10.1007/978-981-16-5011-6_15. 2022


Molecular Studies and Artificial Intelligence

Pinto D.G.; (...); Schmitt F.

Book Chapter. 10.1007/978-3-031-26900-4_17. 2023


Mucinous Lesions

Callé C.; (...); Tan P.-H.

Book Chapter. 10.1007/978-3-031-26900-4_12. 2023


Other Fibroepithelial Lesions

Li J.; (...); Schmitt F.

Book Chapter. 10.1007/978-3-031-26900-4_9. 2023


Other Uncommon Lesions

Ni Y.; (...); Schmitt F.

Book Chapter. 10.1007/978-3-031-26900-4_14. 2023


Papillary Lesions of the Breast

Field A.S.; (...); Schmitt F.

Book Chapter. 10.1007/978-3-031-26900-4_11. 2023


Special Ancillary Techniques: Immunohistochemistry

Tse G., Tan P.-H., Schmitt F.

Book Chapter. 10.1007/978-3-031-26900-4_16. 2023


Suspicious for Malignancy

Schmitt F.; (...); Lai C.-R.

Book Chapter. 10.1007/978-3-031-28046-7_7. 2023


2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management.

Durante C; (...); Papini E

Article. 10.1530/ETJ-23-0067. 2023

  • Open Access.

360 Health Analysis (H360)-A Comparison of Key Performance Indicators in Breast Cancer Management across Health Institution Settings in Portugal.

Rego IB; (...); Costa L

Article. 10.3390/curroncol30070451. 2023

  • Open Access.

A brief review of the WHO reporting system for lung cytopathology.

Canberk S.; (...); Schmitt FC

Article. 10.1016/j.jasc.2023.04.002. 2023

  • Open Access.

A brief review of the WHO reporting system for pancreaticobiliary cytopathology.

Pitman MB; (...); Field AS

Article. 10.1016/j.jasc.2023.03.002. 2023


A New Cytology Staining Method: A Fast Approach for Rapid On-Site Evaluation on Thyroid Fine-Needle Aspiration Cytology

Alves, PD; (...); Schmitt, F.

Article. 10.1159/000527347. 2023


A Real-World Study Reporting the Use of Foundation Medicine® Testing in Portugal

Pinto, R, Schmitt, F

Article. 10.3390/jmp4030014. 2023

  • Open Access.

A Tribute to our Editor on His 75th Birthday

Kholov?, I; (...); Vrdoljak Mozetic, D

Biographical-Item. 10.1159/000529952. 2023


Assessment of Predictive Biomarkers in Breast Cancer: Challenges and Updates.

Rakha EA; (...); Gallagy G

Article. 10.1159/000525092. 2022

  • Open Access.

Breast Cancer Molecular Subtypes Differentially Express Gluconeogenic Rate-Limiting Enzymes-Obesity as a Crucial Player.

Luís C; (...); Soares R

Article. 10.3390/cancers15204936. 2023

  • Open Access.

Comprehensive Genomic Studies on the Cell Blocks of Pancreatic Cancer

Souza da Silva R.; (...); Schmitt F.

Article. 10.3390/diagnostics14090906. 2024

  • Open Access.

Corrigendum: Evaluation of PIK3CA mutations in advanced ER+/HER2-breast cancer in Portugal – U-PIK Project(Front. Mol. Biosci., (2023), 10, (1082915), 10.3389/fmolb.2023.1082915)

Peixoto A.; (...); Machado J.C.

Correction. 10.3389/fmolb.2024.1298522. 2024

  • Open Access.

COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study.

Vigliar E; (...); Troncone G

Article. 10.1002/cncy.22547. 2022

  • Open Access.

Cytologic diagnosis of "atypical" in serous fluid cytopathology. Approach of the international system for reporting serous fluid cytopathology

Chandra, A, Schmitt, F.

Review. 10.1002/dc.24864. 2022


Challenging the concept of "risk of malignancy" in cytology.

Nikas IP; (...); Schmitt F

Article. 10.1002/cncy.22787. 2023


Digital cytology part 1: digital cytology implementation for practice: a concept paper with review and recommendations from the American Society of Cytopathology Digital Cytology Task Force

Kim, D; (...); Li, Z

Article. 10.1016/j.jasc.2023.11.006. 2024


Digital cytology part 2: artificial intelligence in cytology: a concept paper with review and recommendations from the American Society of Cytopathology Digital Cytology Task Force

Kim, D; (...); Li, Z

Article. 10.1016/j.jasc.2023.11.005. 2024


Editorial: Cancer diagnostics in solid tumors-from pathology to precision oncology.

Malapelle U; (...); Schmitt F

Editorial Material. 10.3389/fmolb.2023.1150641. 2023

  • Open Access.

Evaluating Diagnostic Clarity: The Comparative Efficacy of BlueStain in Serous Effusion Cytology under the International System for Reporting Serous Fluid Cytopathology Reporting Framework

Alves P.M.; (...); Schmitt F.C.

Article. 10.3390/diagnostics14111074. 2024

  • Open Access.

Evaluation of PIK3CA mutations in advanced ER+/HER2-breast cancer in Portugal - U-PIK Project.

Peixoto A; (...); Machado JC

Article. 10.3389/fmolb.2023.1082915. 2023

  • Open Access.

Follicular Growth Pattern Disease on Thyroid Fine-needle Aspiration Biopsy.

Tastekin E, Canberk S, Schmitt FC

Article. 10.4274/balkanmedj.galenos.2022.2022-5-17. 2022

  • Open Access.

Immunohistochemistry Applied to Breast Cytological Material.

Pinto D, Schmitt FC

Article. 10.1159/000522542. 2022

  • Open Access.

Impact of the 3rd Edition of the Bethesda System for Reporting Thyroid Cytopathology on Grey Zone Categories.

Guerreiro SC; (...); Canberk S

Article. 10.1159/000534884. 2023


Investigação Clínica da Iniciativa do Investigador em Portugal: Identificação de Problemas e Propostas para Melhoria. - Investigator-Led Clinical Research in PortugalProblem Identification and Proposals for Improvement.

Ferreira, JP; (...); Resende Oliveira, C

Article. 2023


Investigator-Led Clinical Research in Portugal: Problem Identification and Proposals for Improvement

Ferreira, JP; (...); Oliveira, CR

Article. 10.20344/amp.19333. 2023

  • Open Access.

Invisible for a few but essential for many: the role of Histotechnologists in the establishment of digital pathology

Magalhaes, G; (...); Schmitt, F.

Article. 10.1080/01478885.2023.2268297. 2023


Minimally Invasive, Maximally Effective: The Power of Precision Cytoanalysis on Effusion Samples?A Comprehensive Exploration from Traditional Methods to Innovative Approaches

Souza da Silva, R, Schmitt, F.

Article. 10.1016/j.path.2024.04.008. 2024


Molecular testing in cytology

Schmitt, F., Yang, Z, Esebua, M

Editorial Material. 10.1002/dc.25071. 2023


Molecular/biomarker testing in lung cytology: A practical approach

Schmitt, F., Lozano, MD

Article. 10.1002/dc.25054. 2023


Nerve growth factor inducible (VGF) is a secreted mediator for metastatic breast cancer tropism to the brain

Carvalho R.; (...); Ribeiro A.S.

Article. 10.1002/path.6319. 2024


New Quantum-Dot-Based Fluorescent Immunosensor for Cancer Biomarker Detection

Sousa, MP; (...); Moreira, FTC

Article. 10.3390/chemosensors10120518. 2022

  • Open Access.

Next generation sequencing of breast cancer in the neoadjuvant setting.

Mesquita ASA; (...); Schmitt F

Article. 10.1159/000533810. 2023


NSCLC Subtyping in Conventional Cytology: Results of the International Association for the Study of Lung Cancer Cytology Working Group Survey to Determine Specific Cytomorphologic Criteria for Adenocarcinoma and Squamous Cell Carcinoma.

Jain D; (...); Bubendorf L

Article. 10.1016/j.jtho.2022.02.013. 2022

  • Open Access.

Optimal Assessment of Metastatic Breast Carcinoma: The Value of Cytopathology Combined with Molecular Analysis

Souza da Silva, R, Schmitt, F.

Article. 10.3390/jmp3040028. 2022

  • Open Access.

Overcoming Pitfalls in Breast Fine-Needle Aspiration Cytology: A Practical Review

Gomes Pinto D., Schmitt F.C.

Review. 10.1159/000539692. 2024


PD-L1 tumor expression is associated with poor prognosis and systemic immunosuppression in glioblastoma

Noronha, C; (...); Paredes, J

Article. 10.1007/s11060-021-03907-3. 2022


Performance of the Bethesda System for Reporting Thyroid Cytology in Multi-Institutional Large Cohort of Pediatric Thyroid Nodules: A Detailed Analysis.

Canberk S; (...); Schmitt F

Article. 10.3390/diagnostics12010179. 2022

  • Open Access.

Performance of the Bethesda System for Reporting Thyroid Cytology in Multi-Institutional Large Cohort of Pediatric Thyroid Nodules: A Detailed Analysis.

Canberk, S; (...); Schmitt, F

Article. 2022


Reporting of Surgically Removed Lymph Nodes for Breast Tumors: Recommendations From the International Collaboration on Cancer Reporting.

Cserni G; (...); Tan PH

Article. 10.5858/arpa.2022-0060-RA. 2022

  • Open Access.

Resistance to endocrine therapy in HR plus and/or HER2+breast cancer: the most promising predictive biomarkers

Miranda, F; (...); Schmitt, F.

Review. 10.1007/s11033-021-06863-3. 2022


Retrospective study to estimate the prevalence and describe the clinicopathological characteristics, treatments received, and outcomes of HER2-low breast cancer

Viale, G; (...); de Giorgio-Miller, V

Article. 10.1016/j.esmoop.2023.101615. 2023

  • Open Access.

Solid Carcinoma of the Canine Mammary Gland: a Histological Type or Tumour Cell Arrangement?

Nakagaki KY; (...); Cassali GD

Article. 10.1016/j.jcpa.2021.10.011. 2022


Standardization through education of molecular pathology: a spotlight on the European Masters in Molecular Pathology

Ilié M.; (...); Hofman P.

Review. 10.1007/s00428-024-03933-2. 2024


The 2021 WHO Classification of Tumors of the Pleura: Advances Since the 2015 Classification.

Sauter JL; (...); Travis WD

Article. 10.1016/j.jtho.2021.12.014. 2022

  • Open Access.

The 2023 Bethesda System for Reporting Thyroid Cytopathology.

Ali SZ; (...); VanderLaan PA

Article. 10.1089/thy.2023.0141. 2023


The 2023 Bethesda System for reporting thyroid cytopathology.

Ali SZ; (...); VanderLaan PA

Article. 10.1016/j.jasc.2023.05.005. 2023


The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms (vol 36, pg 1720, 2022)

Alaggio, R; (...); Zhao, WL

Correction. 10.1038/s41375-023-01962-5. 2023

  • Open Access.

The current state of digital cytology and artificial intelligence (AI): global survey results from the American Society of Cytopathology Digital Cytology Task Force

Kim, D; (...); Li, Z

Article. 10.1016/j.jasc.2024.04.003. 2024

  • Open Access.

The International System for Reporting Serous Fluid Cytopathology: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy Studies

Jamal F.E.; (...); Nikas I.P.

Review. 10.1097/PAP.0000000000000454. 2024


The international system for reporting serous fluid cytopathology: The initial project survey

VandenBussche, CJ; (...); Kurtycz, DFI

Article. 10.1111/cyt.13218. 2023

  • Open Access.

The mitochondrial enzyme FAHD1 regulates complex II activity in breast cancer cells and is indispensable for basal BT-20 cells in vitro.

Holzknecht M; (...); Jansen-Duerr P

Article. 10.1002/1873-3468.14462. 2022

  • Open Access.

The rationale for the development and publication of the World Health Organization reporting systems for cytopathology and a brief overview of the first editions of the lung and pancreaticobiliary systems.

Field AS; (...); Schmitt F

Article. 10.1002/cncy.22757. 2023

  • Open Access.

The World Health Organization Reporting System for Lung Cytopathology

Schmitt, F.; (...); Field, AS

Article. 10.1159/000527580. 2023


The World Health Organization Reporting System for Pancreaticobiliary Cytopathology

Pitman, MB; (...); Field, AS

Review. 10.1159/000527912. 2023


The World Health Organization Reporting System for Pancreaticobiliary Cytopathology: Overview and Summary

Centeno B.A.; (...); Pitman M.B.

Review. 10.1002/cncy.22806. 2024


Tissue management in precision medicine: What the pathologist needs to know in the molecular era

da Silva, RS; (...); Schmitt, F.

Review. 10.3389/fmolb.2022.983102. 2022

  • Open Access.

Partilhar